Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Panacise Bio, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Panacise Bio, Inc.

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: W3AFTLZB6EL4

Founded: —Source: [GOV]
Headquarters: Chapel Hill, North CarolinaSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Panacise Bio, Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $224,991 in 2018. These are non-dilutive federal research grants, not equity financing. The company is based in Chapel Hill, North Carolina.

Funding rounds

1 rounds

STTR Phase I award (HHS)GrantMay 2018Source: [GOV]
$225K
—post-money

Investors

No investors recorded yet for Panacise Bio, Inc..

Add an investor

People

Leadership

JINGJING LIPrincipal investigatorSince 2018Source: [GOV]

Acquisitions

Panacise Bio, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Panacise Bio, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.